Results of an Italian CORE-IMMUNO study: Safety and clinical-related biomarkers as predictors of immunotherapy (IT) benefit in real-world treatment of various advanced tumors (ATs).

Cristina Masini,Annalisa Berselli,Alessandra Romagnani,Candida Bonelli,Emanuela Fantinel,M Pagano,Maria Banzi,Giuseppe Prati,Elisa Gasparini,G. Moretti,E. Gervasi,R Gnoni,Giovanna Stridi,Carmine Pinto

Results of an Italian CORE-IMMUNO study: Safety and clinical-related biomarkers as predictors of immunotherapy (IT) benefit in real-world treatment of various advanced tumors (ATs).

2019

Cristina Masini
Annalisa Berselli
Alessandra Romagnani
Candida Bonelli
Emanuela Fantinel
M Pagano
Maria Banzi
Giuseppe Prati
Elisa Gasparini
G. Moretti
E. Gervasi
R Gnoni
Giovanna Stridi
Carmine Pinto

e14156Background: Checkpoint inhibitors in cancer therapy have shown survival benefits in the treatment of several ATs. However, the risk of serious side effects seems greater in certain types of t...

Keywords:

Oncology
Immunotherapy
Biomarker (medicine)
Pathology
Internal medicine
Medicine
cancer therapy
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations